Azinma IV injection 1500 by Takeda Pharmaceutical contains Apadamtase alpha (genetically recombined) / Sinaxadamtase alpha (genetically recombined). This injectable drug, YJ code 3399418D1020, is supplied as 1,500 IU per bottle (with dissolving solution) and is a recombinant ADAMTS13 enzyme used for the treatment of congenital thrombotic thrombocytopenic purpura.
Azinma IV injection 1500
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →